Description: KnockdownefficacycomparisonofGenMuteTransfectionReagent(upperpanel)vs.Dharmafect4siRNATransfectionReagent(middlepanel)andLipofectamine2000(lowerpanel)onHEK293cells.siRNAtargetingrenillaluciferaseatdifferentfinalconcentrationsrangingfrom0.5to20nMwasco-transfectedwithrenillaluciferasegene(0.5µgofpRL-CMVDNAperwell)bytheabovethreetransfectionreagentspermanufacturers"protocolsintoHEK293cellsgrowingona24-wellplate.Renillaluciferaseactivitywasdetermined24hafterpostco-transfectionwithrenillaluciferasedeterminationsystem(Promega).Theluminescencewasmeasuredfrom5.0µloflysateduring10sintegrationwithaluminometer(BeckmanCoulterLD400).Luciferaseactivitywasexpressedaslightunitsintegratedover10s(RLU)andnormalizedpermgofcellproteinbyusingtheBCAassay.Theerrorsbarsrepresentstandarddeviationderivedfromtriplicateexperiments.Luciferase-silencingefficiencywascalculatedrelativetountreatedcells.WhileGenMuteandDharmafect4reagentsdeliveredsignificantgenesilencingfrom1.0nMofrenillaluciferasesiRNA,lipofectamine2000gavegoodknockdownonlyafter30nM(datanotshown).
GenMuteReagentisanovelbiodegradablenon-LiposomalsiRNA/miRNA&DNAdeliverytool.WithourproprietarypHDependentConformationalChange(PDCC)technology,thebiodegradabletransfectionreagentwasformulatedbyadditionofpre-screenedhydrophobicgroupstoitssidechain,makingGenMuteReagentaversatileandmostpowerfulgenedeliverytoolinthemarket.GenMuteReagenthavebeenvalidatedtoeffectivelyandreproducIBLytransfectsinglesiRNA/miRNAorco-transfectDNA/siRNAorDNA/miRNAtovarietyofmammaliancells.
Size&content:
-GenMuteReagent,1.0mL,sufficientfor~2,000reactionsbasedontransfecting5.0pmolsiRNAormiRNAmimicsin24-wellplate.
-GenMuteTransfectionBuffer(5x),formulatedformaximaltransfectionefficiency,8.0mLtomake40mLworkingsolution.
Applications:
-SinglesiRNAtransfectionorDNA/siRNAco-transfectiontovarietyofmammaliancells.
-SinglemiRNA,miRNAmimicsorinhibitorstransfectionorDNA/miRNAorDNA/miRNAmimicsco-transfectiontovarietyofmammaliancells.
Storage:
Storeat4°CforGenMuteReagentandRTforGenMuteTransfectionBuffer(5x). Ifstoredproperly,theproductisstablefor12monthsorlonger.
Advantages:
-Excellentsilencingatlowconcentrationswithonly1.0nMsiRNA/miRNAmimics
-Minimizingnon-specificandofftargeteffectsinthecell
-Onetubereaction
-Bestforbroadmammaliancells
-Verylowcytotoxicity
-Veryaffordable
ComparisonsofSilencingEfficacyofGenMutesiRNA&DNATransfectionReagentwithBrandNameProducts
ExcellentsilencingofendogenouslyexpressedKIF11(alsoknownasEg5)inHEK293cellswith0.5µlofGenMutereagentand5.0pmolEg5siRNAperwellof24-wellplate.KIF11(alsoknownasEg5)encodesamotorproteinthatbelongstothekinesin-likeproteinfamilyinvolvedinchromosomepositioningandbipolarspindleformationduringcellmitosis.AreductioninKIF11levelscausesmitoticarrest.GenMutereagenteffectivelydeliversEg5siRNA(final10nM,rightpanel)toHEK293cellsatonly0.5µlperwellof24-wellplatevs.negativecontrol(final10nM.leftpanel).Comparedwithnegativecontrol(leftpanel),phenotypeof"rounded-up"293cellswerevisualized24hoursposttransfection(rightpanel)withaNikonmicroscope.
GenMuteTransfectionReagentknockeddownendogenouslaminA/CgeneexpressioninHelacells.AsiRNAtargetinglaminA/Cgene(rightpanel)andashamsiRNA(leftpanel)wereintroducedintoHelacells(final1.0nM)byGenMuteTransfectionReagent.LaminA/Cgenesilencingwasmonitored24hposttransfectionbyimmunofluorescence.LaminA/CwasprobedwithamousemonoclonallaminA/CspecificantibodyfollowedbyadditionofFITC-conjugatedanti-mouseantibodies.QuantitativeanalysisshowedthatlaminsiRNAat1.0nMdeliveredbyGenMuteTransfectionReagentknockeddown94%endogenouslyexpressedlaminA/CinHelacells.
DataSheet&Protocol
-AProtocolforsiRNATransfectionandDNA/siRNACo-Tranafection
-AProtocolformiRNAMimicsTransfectionandDNA/miRNACo-Transfection
-AProtocolforDNATransfectiontoMammalianCells
Torequestafreetrialsample,pleaseCreateAnAccountwithustoenteryourshippingaddressandemailusatorder@Signagen.com
SignaGen公司是一家专注于开发和生产基因转导工具的企业,服务于生物医学研究领域。借助我们独有的技术平台(美国专利商标局号码为 072308和61135606),SignaGen已经成功开发出三大类 DNA/siRNA转染试剂,经验证我们的产品比市场上主导产品效率更高,细胞毒性更低。更重要的是我们提供一个合理的价位。